Henry Kopeček Awarded $1.7M Grant to Study New Approaches of B Cell Malignancies Treatment
The National Cancer Institute of the National Institutes of Health awarded Distinguished Professor Jindřich Henry Kopeček a 5-year RO1 grant of $1,744,220 to continue his lab's studies of "drug-free macromolecular therapeutics".
Kopeček, Research Professor Jiyuan Yang, Postdoctoral Fellow Lian Li, Professor Paul Shami and others will concentrate on developing lymphoma therapeutics based on antibody biorecognition combined with receptor cross-linking.
